Chromium Picolinate

The main forms available are chromium picolinate tablets, capsules or tablets, intended for daily oral administration. Products on the market may contain varying doses of elemental chromium, the most common of which range from 100 to 200 μg per dose.

These forms are designed for easy administration, greater stability and easy integration into the daily routine.

Taking chromium picolinate is particularly recommended for:

• supporting blood sugar balance and reducing fluctuations in blood sugar levels;
• optimising insulin sensitivity, particularly in people at metabolic risk;
• supporting weight management, as an adjunct to a balanced diet;
• supporting the metabolism of carbohydrates, fats and proteins;
• improving the lipid profile by increasing HDL levels and reducing triglycerides;
• maintain a constant level of physical and mental energy.

It is particularly beneficial for people whose diet is high in simple carbohydrates, for those who suffer from frequent food cravings or significant fluctuations in energy levels, as well as for people interested in preventing metabolic imbalances.

The usual recommended dose for adults is 1 tablet or capsule per day, equivalent to 100–200 μg of elemental chromium, to be taken preferably with meals to optimise absorption and digestive tolerance.

It is recommended not to exceed the daily dose indicated by the manufacturer or your doctor. Long-term use should be part of a varied diet and a healthy lifestyle, as the supplement is not intended to replace a balanced diet.

Chromium picolinate is contraindicated:

• for people with known hypersensitivity to chromium or any of the excipients;
• children, unless recommended by a doctor;
• for people with severe kidney or liver disease, without specialist advice.

In the case of pregnancy and breastfeeding, administration must be assessed on an individual basis, based on the risk-benefit ratio.

The use of chromium picolinate requires caution in people with diabetes mellitus undergoing drug treatment, as it may enhance the effect of insulin or oral antidiabetic drugs. Monitoring of blood glucose levels is recommended during the first few weeks of administration.

Chromium is also involved in cellular protection mechanisms; there is evidence suggesting its role in maintaining DNA integrity and in processes associated with longevity and cognitive health.

Chromium picolinate is generally well tolerated. The following may rarely occur:

• mild gastrointestinal disturbances (nausea, bloating);
• headache or transient dizziness;
• minor skin reactions, in isolated cases.

These symptoms are usually mild and reversible upon discontinuation of treatment.

Chromium picolinate may interact with:

• Insulin and oral antidiabetics, enhancing the hypoglycaemic effect
• Non-steroidal anti-inflammatory drugs
• Levothyroxine
• Supplements rich in zinc or iron, which may compete for intestinal absorption.

Chromium overdose is rare, but long-term excessive intake may cause mineral imbalances or kidney or liver damage. Adherence to the recommended dose is essential for safe use.

The product should be stored at room temperature, in a dry place, away from light and heat sources. Keep out of the reach and sight of children. The packaging must be kept tightly closed to prevent the active ingredients from deteriorating.

• WebMD, Chromium
• PubMed, Chromium picolinate supplementation for overweight or obese adults
• Clinical Nutrition Research, Effects of chromium picolinate supplementation on cardiometabolic biomarkers in patients with type 2 diabetes mellitus: a randomised clinical trial
• Sage Journals, A comparative study on chromium: therapeutic uses and toxicological effects on human health